Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Locker GY, Hamilton S, Harris J, et al. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol. 2006;24(33):5313–27.
2. Araujo RL, Gönen M, Allen P, et al. Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. Ann Surg Oncol. 2015;22(9):3087–93.
3. Neofytou K, Giakoustidis A, Neves MC, et al. Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases. Langenbecks Arch Surg. 2017;402(4):599–605.
4. Sakamoto Y, Miyamoto Y, Beppu T, et al. Post-chemotherapeutic CEA and CA19-9 are prognostic factors in patients with colorectal liver metastases treated with hepatic resection after oxaliplatin-based chemotherapy. Anticancer Res. 2015;35(4):2359–68.
5. Hori Y, Seo S, Yoh T, et al. Impact of preoperative CEA uptrend on survival outcomes in patients with colorectal liver metastasis after hepatectomy. Ann Surg Oncol. 2022. https://doi.org/10.1245/s10434-022-11973-8.